The present invention provides a light cosmetology or light therapy light-emitting sheet having excellent conformability to the skin and excellent wearing feeling. The present invention relates to a light cosmetology or light therapy organic electroluminescence sheet used in light cosmetology or light therapy application, the organic electroluminescence sheet including an organic electroluminescence device having a structure in which multiple layers are laminated on a sheet-like flexible substrate and having a thickness of 10 to 100 μm.

Systems, methods and computer-readable media are disclosed for providing therapeutic auditory stimulation. Consistent with disclosed embodiments, a system for providing therapeutic auditory stimulation may comprise a diagnostic unit that computes an EEG spectral density of a patient and a heart rate spectral density of a patient and provides values for one or more EEG frequency bands and one or more heart rate frequency bands. The system may also comprise a therapy unit that generates, based on the provided values, one or more stimulation waveforms corresponding to one or more of the EEG frequency bands and provides the stimulation waveforms for therapeutic auditory stimulation. The stimulation waveforms may comprise audible carrier frequencies modulated by signals with frequencies that vary exponentially with time. The EEG frequency bands may comprise the delta, theta, alpha, beta 1, beta 2, and gamma EEG frequency hands.

The present application is directed to systems, devices, and methods for diagnosing, preventing, and treating diseases and disorders through photobiomodulation therapy, either alone or in combination with one or more other therapies. More particularly, the present invention provides photon source devices configured to deliver light to a portion of an organism, which causes a physiological response within that light exposed organism. The invention also provides a system which includes one or more photon source devices and functionality for diagnosing or assessing a disease or disorder, and for monitoring responsiveness of the disease or disorder to treatment with the therapeutic light. Additionally, this application is directed to utilizing the present systems and devices in combination with known adjunctive therapies including devices, services, drugs, biologics, genetics and supplements to produce synergistic optimal therapeutic outcomes.

The embodiments herein provide a method for producing activated carbonaceous balls. The method includes a step of crushing and sizing raw coconut shells to form coconut shell granules having a diameter of about 0.02 mm-2.36 mm, preferably 0.075 mm-1.18 mm. The method includes a step of mixing pure water to a food grade powder appropriately and boiling it slowly at 15° C.-80° C. to obtain a water-food grade powder mixture. The method includes a step of adding the water-food grade powder mixture 20-40% by weight to the coconut shell granules 100% by weight to obtain a slurry in a pourability condition. The method includes a step of pouring the slurry into a pill making machine equipped with a mold of 3 mm, 5 mm, and 8 mm in diameters selectively to produce the spherical carbon tablets. The method includes a step of drying the spherical carbon tablets and carbonizing the spherical carbon tablets to obtain the activated carbonaceous balls.

A method and system for treating a subject with a disorder which provides within the subject at least one photoactivatable drug for treatment of the subject, applies initiation energy from at least one source to generate inside the subject a preferential x-ray flux for generation of Cherenkov radiation (CR) light capable of activating at least one photoactivatable drug, and from the CR light, activating inside the subject the at least one photoactivatable drug to thereby treat the disorder.

This invention relates to a ceramic composite that may be used for various purposes including for assembly into a therapeutic device for treating a human or animal body with irradiation of nonthermal far infrared (FIR) radiation. More specifically, while all FIR-related prior art is only radiating broadband blackbody thermal radiation, said ceramic composite can emit not only the usual blackbody thermal radiation but also the inventive nonthermal FIR-photon radiation in the 3 - 16 .Math.m wavelength spectrum. As a result, the overall measurable radiation in 8 - 14 .Math.m wavelength range from said ceramic composite has an approximated blackbody temperature that is at least 1° C. higher than the actual temperature of said ceramic composite, signifying an effective emissivity greater than 1.0, while 1.0 emissivity is a theoretical limit assigned to an ideal black body and thus unsurpassable. It is an outcome of adding the 3 - 16 .Math.m band of nonthermal FIR-photon radiation to the continuous 4 - 1,000 .Math.m band of blackbody thermal radiation.

Systems, methods and computer-readable media are disclosed for providing therapeutic auditory stimulation. Consistent with disclosed embodiments, a system for providing therapeutic auditory stimulation may comprise a diagnostic unit that computes an EEG spectral density of a patient and a heart rate spectral density of a patient and provides values for one or more EEG frequency bands and one or more heart rate frequency bands. The system may also comprise a therapy unit that generates, based on the provided values, one or more stimulation waveforms corresponding to one or more of the EEG frequency bands and provides the stimulation waveforms for therapeutic auditory stimulation. The stimulation waveforms may comprise audible carrier frequencies modulated by signals with frequencies that vary exponentially with time. The EEG frequency bands may comprise the delta, theta, alpha, beta 1, beta 2, and gamma EEG frequency hands.

The present disclosure relates to the field of beauty instruments, and a skin care assembly are disclosed. The skin care assembly provided in the present disclosure includes a first cover, an electrode, and a cold compress component. The electrode is fixed on the first cover to discharge for a skin. The first cover is defined with a first opening, and the cold compress component is received in the first opening to contact and cool the skin during the electrode discharging for the skin. The electrode may provide a beauty effect to the skin by generating micro-current and radio frequency, and the cold compress component provides a suitable environment temperature for the skin, thus the beauty effect is improved.

The present application is directed to systems, devices, and methods for diagnosing, preventing, and treating diseases and disorders through photobiomodulation therapy, either alone or in combination with one or more other therapies. More particularly, the present invention provides photon source devices configured to deliver light to a portion of an organism, which causes a physiological response within that light exposed organism. The invention also provides a system which includes one or more photon source devices and functionality for diagnosing or assessing a disease or disorder, and for monitoring responsiveness of the disease or disorder to treatment with the therapeutic light. Additionally, this application is directed to utilizing the present systems and devices in combination with known adjunctive therapies including devices, services, drugs, biologics, genetics and supplements to produce synergistic optimal therapeutic outcomes.

The present application is directed to systems, devices, and methods for diagnosing, preventing, and treating diseases and disorders through photobiomodulation therapy, either alone or in combination with one or more other therapies. More particularly, the present invention provides photon source devices configured to deliver light to a portion of an organism, which causes a physiological response within that light exposed organism. The invention also provides a system which includes one or more photon source devices and functionality for diagnosing or assessing a disease or disorder, and for monitoring responsiveness of the disease or disorder to treatment with the therapeutic light. Additionally, this application is directed to utilizing the present systems and devices in combination with known adjunctive therapies including devices, services, drugs, biologics, genetics and supplements to produce synergistic optimal therapeutic outcomes.